What Pharma Resource Group does

Pharma Resource Group, Inc. (PRG) is a privately held pharmaceutical and life sciences advisory and manufacturing services firm founded in 2007 and headquartered in Royersford, Pennsylvania, with a reported employee base of 11-50 and a referenced bench of 60+ industry veterans. The company delivers four interconnected service lines: (1) Consultancy Services — expert technical consultants and full team deployments across analytical sciences, formulation, regulatory, quality, engineering, manufacturing, microbiology, packaging, and technology transfer; (2) Project-Centric Services — business process outsourcing solutions spanning development through commercialization; (3) an ISO-9001 certified GMP Innovation, Product Development and Commercial Manufacturing Center in Royersford, PA; and (4) Innovation and Applied Technologies — advanced manufacturing platforms including continuous flow API manufacturing, continuous finished dosage formulation, in-line Process Analytical Technology, big-data-enabled scale-up, and novel dosage form technologies.

PRG's go-to-market is sales-led and consultative, serving entrepreneurs, innovators, and startups alongside Fortune 100 pharmaceutical, biotech, nutraceutical, OTC, consumer health, and medical device companies. Revenue is generated through professional services engagements (consultancy/project-based fees) and managed services tied to its manufacturing center, with no minimum order quantities (MOQs) — a deliberate commercial wedge against larger CDMOs. The company monetizes engagement scope via time-and-materials and project-based pricing, with public pricing not disclosed.

PRG operates through wholly-owned subsidiaries in Canada (2013), Brazil (2018), and Europe (2019), and strategic alliances in India (2015) and China (2022), giving it a stated footprint across 15 US states/territories and 14 international countries. In April 2026, PRG was acquired by Pinnaql, Inc., a portfolio company of 3 Boomerang Capital, as Pinnaql's third tuck-in deal in 10 months, combining PRG's scientific development and scale-up expertise with Pinnaql's validation, engineering, quality systems, and regulatory compliance capabilities within a scaled, multi-disciplinary advisory platform.

Name

Pharma Resource Group

Legal name

Pharma Resource Group, Inc.

Website

https://pharmarg.com

Company type

Private

Founded year

2007

Operating status

Acquired

Headcount range

11–50 employees

Short description

Pharma Resource Group is a pharmaceutical and life sciences advisory and manufacturing services firm serving entrepreneurs, startups, and Fortune 100 companies across pharma, biotech, nutraceutical, OTC, consumer, and medical device sectors globally. Acquired by Pinnaql in April 2026.

Ownership category

akta.pro rank

Product category

Pharmaceutical and Life Sciences Consulting & Contract Manufacturing Services

NAICS

Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834), Services-Management Consulting Services (8742)

akta.pro primary industry

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

akta.pro secondary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical consulting services
• Life sciences advisory
• Contract manufacturing organization
• GMP product development
• Technology transfer services

Headquarters

HQ city

Drexel Hill

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Consultancy and Technical Consulting Services: PRG deploys highly skilled technical consultants to augment client project teams or lead entire projects and business processes. Consultants are billed based on engagement scope, typically project-based or time-and-materials arrangements. Services span Analytical Sciences, Change Control Management, Cleaning Development and Validation, Engineering, Manufacturing, Microbiology, Packaging, Procurement and Supply Chain, Project Management, Quality Assurance and Control, Regulatory, Raw Material Science, Research and Development, Statistics, Technical Writing/Document Label Review, and Technology Transfer.
2. Project-Based Solutions: PRG provides project-centric engagements including pharmaceutical development projects (oral, liquid, solid, and semi-solid dose prototype development; product and process characterization; GMP manufacturing and packaging for clinical and consumer studies; technology transfer; commercialization), pharmaceutical technical writing (developmental, quality, regulatory), and quality and compliance services (consent decree remediation, deactivation and discontinued product artifact remediation).
3. Product Development and Manufacturing: PRG operates its own Innovation, Product Development and GMP Commercial Manufacturing Center offering manufacturing services to innovators, entrepreneurs, and established consumer, OTC, nutraceutical, ethical pharmaceutical, and device companies. Revenue is generated through development fees, manufacturing runs, and scale-up services without imposing minimum order quantities.
4. Applied Innovation and Technology Platforms: PRG takes on new, breakthrough technology platforms into pilot and commercialization alongside academia and technology partners, demonstrating innovative manufacturing platforms through commercial manufacturing. Revenue derived from technology development, pilot programs, and commercial manufacturing of novel platforms including continuous flow API and novel dosage forms.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Pharma Resource Group provides life sciences advisory, technical consulting, project-based outsourcing, and GMP product development/commercial manufacturing services to pharmaceutical, biotech, nutraceutical, OTC, consumer, and medical device companies. It operates an ISO-9001 certified Innovation, Product Development and Commercial Manufacturing Center in Royersford, Pennsylvania, deploys 60+ industry veteran consultants, and applies proprietary continuous manufacturing and Process Analytical Technology (PAT) platforms — all without imposing minimum order quantities.

Product overview

Pharma Resource Group (PRG) offers a comprehensive suite of pharmaceutical and life sciences advisory services structured around four interconnected pillars: Consultancy Services (expert technical consultants and full team deployments), Project-Centric Services (BPO solutions spanning development through commercialization), an Innovation/Product Development and GMP Commercial Manufacturing Center (ISO-9001 certified facility), and Innovation and Applied Technologies (advanced manufacturing platforms). The company serves the pharmaceutical, biotech, nutraceutical, OTC, consumer, and medical device sectors from concept through commercialization, with global operations spanning North America, South America, Europe, and Asia-Pacific.

Differentiator

Problem solved

Functional benefit

Products and services

• Consultancy Services Deployment of expert technical consultants and full project teams across Analytical Sciences, Change Control Management, Cleaning Development and Validation, Engineering, Manufacturing, Microbiology, Packaging, Procurement and Supply Chain, Project Management, Quality Assurance and Control, Regulatory, Raw Material Science, R&D, Statistics, Technical Writing, and Technology Transfer — for pharma, biotech, nutraceutical, OTC, consumer, and medical device clients.
• Project-Centric Services Business Process Outsourcing (BPO) project solutions spanning Analytical, Cleaning Development and Validation, Change Control Management, Technology Transfer, Package Development, Raw Material Assessment and Characterization, Safety in Controlled/GMP environments, Stability, and Technical Writing and Review, plus pharmaceutical development (oral, liquid, solid, semi-solid dose prototype development, product and process characterization, GMP manufacturing and packaging, and commercialization).
• Innovation, Product Development and Commercial Manufacturing Center ISO-9001 and GMP-certified facility offering collaborative office space, product development suites, commercial manufacturing suites, analytical laboratories, and innovative equipment, backed by a 60+ industry veteran team, for clients who cannot meet typical CMO minimum order quantities.
• Innovation and Applied Technologies Advanced manufacturing technology platforms including continuous flow API manufacturing, continuous technologies for finished dosage formulation, cleaning technology support and innovation, and novel dosage form technologies (oral, liquid, solid, semi-solid). Uses flexible big-data platforms and in-line Process Analytical Technology (PAT) for model-based scale-up and technology transfer, demonstrated via commercial manufacturing and pilot programs.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• PinnaqlcoreStrategic or Co-development Partner · 30 April 2026Pinnaql, a portfolio company of 3 Boomerang Capital, acquired Pharma Resource Group in April 2026. This was Pinnaql's third tuck-in acquisition in 10 months. The acquisition combines PRG's scientific development expertise with Pinnaql's validation, engineering, quality systems, and regulatory compliance capabilities to support clients from laboratory innovation through manufacturing readiness. PRG's capabilities in scientific development and scale-up complement Pinnaql's existing focus on creating a scaled, multi-disciplinary advisory platform.
• Strategic Alliance Partner (Jiangsu, China)minorStrategic or Co-development Partner · 1 January 2022PRG established a strategic alliance with a complementary organization in Jiangsu (north of Shanghai), China in 2022. This partnership enables PRG US to provide high-quality services and solutions to address Asia-Pacific clients' needs.
• Pharma Resource Group Europe SASU (PRG Europe)coreOthers · 1 July 2019Pharma Resource Group Europe SASU (PRG Europe) was formed in Paris, France in July 2019 to serve European projects. This is a wholly-owned subsidiary of PRG.
• Pharma Resource Group Brazil Servicos Farmaceuticos, Ltda. (PRG Brazil)coreOthers · 1 October 2018Pharma Resource Group Brazil Servicos Farmaceuticos, Ltda. (PRG Brazil) was formed in Sao Paulo, Brazil in October 2018 to address South America projects. This is a wholly-owned subsidiary of PRG.
• Strategic Alliance Partner (Hyderabad, India)minorStrategic or Co-development Partner · 1 January 2015PRG established a strategic alliance with a complementary organization in Hyderabad, India in 2015. This partnership enables PRG US to provide high-quality services and solutions to address Asia-Pacific clients' needs, extending the company's global reach into one of the world's largest pharmaceutical markets.
• Third-Party Development and Clinical Manufacturing PartnerminorStrategic or Co-development Partner · 1 January 2014In 2014, through a well-established business relationship with a third-party development and clinical manufacturing partner, PRG expanded its offerings to include product, analytical, and technology development services and solutions.
• Pharma Resource Group Canada, Inc. (PRG Canada)coreOthers · 1 September 2013Pharma Resource Group Canada, Inc. (PRG Canada) was formed in British Columbia, Canada in September 2013 with operations in Toronto, Canada, to expand upon North America projects. This is a wholly-owned subsidiary of PRG.
• Academia and Technology PartnersminorStrategic or Co-development PartnerPRG works together with academia and technology partners to take on new, breakthrough technology platforms into pilot and commercialization. Based on PRG's own production efforts in support of critical medicines availability as well as client projects, the company demonstrates innovative manufacturing platforms through commercial manufacturing.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Thermo Fisher Scientific (Patheon): Through its Patheon CDMO business, Thermo Fisher provides pharmaceutical development services, clinical and commercial manufacturing, and packaging. Broad incumbent competing across nearly every service PRG offers.
• Charles River Laboratories: Large CRO/CDMO providing discovery, safety assessment, CDMO, and consulting services across the pharma and biotech value chain. Broader incumbent offering overlapping development, manufacturing, and advisory services to similar client types.
• Lonza: Global CDMO leader providing API and biopharmaceutical manufacturing, including small-molecule and biologics services. Competes in PRG's API and finished-dose manufacturing space but at vastly greater scale and geographic footprint.

Direct peers

• PharmaLex: Global pharma consulting and services provider spanning regulatory affairs, development consulting, and quality/compliance. Closely mirrors PRG's consultancy plus development services model for pharma and biotech clients.
• Catalent: Global CDMO offering development, manufacturing, and packaging services across oral, injectable, and biologic dosage forms. Most directly comparable large-scale peer to PRG's GMP Commercial Manufacturing Center and product-development services.
• ProPharma Group: Pharmaceutical consulting and compliance services firm offering regulatory, quality, and clinical services to pharma and biotech. Directly comparable consultancy arm to PRG with overlapping regulatory and quality practice areas.
• Cambrex: CDMO providing small-molecule API development and manufacturing, finished dosage forms, and analytical services. Direct competitor in PRG's API and finished-dose manufacturing niche, with deeper scale.
• Alcami: US-based CDMO providing analytical services, formulation development, and GMP manufacturing for small-to-mid pharma and biotech clients. Closest mid-market peer in scale and customer profile to PRG, including innovator/startup engagement models.

Emerging players

• Frontage Laboratories: CRO/CDMO offering bioanalytical, CMC, formulation development, and GMP manufacturing services to pharma and biotech. Comparable in the integrated analytical-to-manufacturing service mix and small/mid-cap customer focus.
• Velesco Pharmaceutical Services: Small US-based CDMO focused on early-phase formulation development, analytical method development, and clinical-supply manufacturing for virtual and small pharma companies. Closest emerging-player peer to PRG's small-innovator niche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Resource Group